DOI: 10.12890/2025_005677

Respiratory-predominant relapsing polychondritis: the role of PET scan in making this challenging diagnosis

Authors

  • Daniela Alves Department of Internal Medicine, Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal
  • João Fonseca Department of Internal Medicine, Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal
  • Miguel Martins Department of Internal Medicine, Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal
  • Valter Duarte Department of Internal Medicine, Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal
  • Gisela Gonçalves Department of Internal Medicine, Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal
  • Pedro Lopes Department of Internal Medicine, Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal

dralves94@gmail.com

Keywords

Myelodysplasia, autoinflammatory disease, VEXAS syndrome, respiratory-predominant, relapsing polychondritis

Abstract

Relapsing polychondritis is a rare, immune-mediated, multisystemic disease characterized by recurrent inflammation of cartilaginous and proteoglycan-rich tissues. Its diagnosis may be challenging due to its rarity and wide clinical variability. It can be primary or associated with other autoimmune conditions. Recently, it has been associated with an autoinflammatory disease known as vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome. We present a case of a 65-year-old man with respiratory-predominant relapsing polychondritis. This case illustrates the diagnostic complexity of relapsing polychondritis, where multiple initial investigations were inconclusive. We highlight the pivotal role of the fluorine-18 fluorodeoxyglucose positron emission tomography scan, which provided the key evidence of cartilaginous inflammation, ultimately guiding the diagnosis in this atypical presentation.

View the entire article

Downloads

References

  1. Bica BERG, de Souza AWS, Pereira IA. Unveiling the clinical spectrum of relapsing polychondritis: insights into its pathogenesis, novel monogenic causes, and therapeutic strategies. Adv Rheumatol 2024;64:29. doi: 10.1186/s42358-024-00365-z
  2. Damiani JM, Levine HL. Relapsing polychondritis--report of ten cases. Laryngoscope 1979;89:929-46.
  3. Sharma A, Gnanapandithan K, Sharma K, Sharma S. Relapsing polychondritis: a review. Clin Rheumatol 2013;32:1575-1583. doi: 10.1007/s10067-013-2328-x
  4. Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS. Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 2002;31:384-395. doi: 10.1053/sarh.2002.32586
  5. Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. N Engl J Med 2020;383:2628-2638. doi: 10.1056/NEJMoa2026834
  6. Khitri MY, Guedon AF, Georgin-Lavialle S, Terrier B, Saadoun D, Seguier J, et al. Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients. RMD Open 2022;8:e002255. doi: 10.1136/rmdopen-2022-002255
  7. McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: Prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976;55:193-215.
  8. Michet CJ, McKenna CH, Luthra HS, O’Fallon WM. Relapsing polychondritis: Survival and predictive role of early disease manifestations. Ann Inter Med 1986;104:74-78. doi: 10.7326/0003-4819-104-1-74
  9. Rednic S, Damian L, Talarico R, Scirè CA, Tobias A, Costedoat-Chalumeau N, et al. Relapsing polychondritis: state of the art on clinical practice guidelines. RMD Open 2018;4:e000788. doi: 10.1136/rmdopen-2018-000788

Published

2025-09-08

How to Cite

1.
Alves D, Fonseca J, Martins M, Duarte V, Gonçalves G, Lopes P. Respiratory-predominant relapsing polychondritis: the role of PET scan in making this challenging diagnosis. EJCRIM [Internet]. 2025 Sep. 8 [cited 2026 Nov. 4];12(10). Available from: https://ejcrim.com/index.php/ejcrim/article/view/5677

Most read articles by the same author(s)